Abstract. Three mutations of the membrane-binding re#on of the Semliki Forest virus (SFV) 1062 polypeptide (the precursor for virion E3 and E2) have been made by oligonucleotide-directed mutagenesis of a cDNA clone encoding the SFV structural proteins. One of the mutations (A2) substitutes a Glu for an Ala in the middle of the hydrophobic stretch which spans the bilayer. Al and A3 alter the two basic charged amino acids in the cytoplasmic domain next to the hydrophobic region. The wild-type charge cluster of Arg-Ser-Lys (+2) has been changed to Gly-SerMet (0;A3) or to Gly-Ser-Glu (-I;A 1). The mutant p62 proteins have been analyzed both in the presence and the absence of E 1, the other half of the heterodimer spike complex of SFV. The mutant proteins expressed in COS-7 cells are glycosylated and are of the expected sizes. When co-expressed with E 1, all three mutants are cleaved to yield the E2 protein and transported to the surface of COS-7 cells. When expressed in the absence of E l, the mutant p62 proteins remain uncleaved but still reach the cell surface. Once at the cell surface, all three mutants, when co-expressed with El, can promote low pH-triggered cell-cell fusion. These results show that the three mutant p62/E2 proteins are still membrane associated in a functionally unaltered way.
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T RANSMEMBRANE proteins that span the lipid bilayer once can be divided into three protein domains: lumenal (or external), transmembrane (or hydrophobic), and cytoplasmic. Some of these proteins have been shown to be oriented in the membrane with their COOH-terminus in the cytoplasm (group I membrane proteins; see reference 16) while others have the opposite orientation (group II). We are attempting to define the features of group I transmembrane proteins that lead to the establishment and maintenance of their three-domain structure.
A large number of biochemical and structural studies (e.g., 8, 13, 23, 42, 47, 49, 51) on group I proteins have demonstrated that the transmembrane protein domain consists of a long stretch (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) of hydrophobic and neutral amino acid residues. In addition, sequence comparisons between group I proteins have revealed that the hydrophobic peptide is always followed by one or more positively charged residues (the "charge cluster") immediately preceding the cytoplasmic domain. These basic residues have also been implicated in membrane binding, e.g., by interacting with negatively charged phospholipid headgroups on the cytoplasmic membrane surface (47, 51) . The observation that the transmembrane peptide and the charge cluster of group I proteins are generally encoded by one single exon (e.g. 20, 34) supports the notion that the two consensus features are functionally related. Our working hypothesis is that the region containing the hydrophobic transmembrane domain and the charge cluster of the cytoplasmic domain make up the membranebinding region of group I proteins.
It has been postulated that the generation of the threedomain structure of group I proteins occurs co-translationally. Group I proteins have been shown to be inserted across the endoplasmic reticulum membrane starting from their NH2-termini using the same mechanism as secretory proteins (see, e.g., 25, 26, and 33) . However, in contrast to secretory proteins, where chain transfer is completed, translocation of a membrane protein chain is thought to be arrested at the level of its hydrophobic segment by a "stop transfer signal," thus resulting in a transmembrane protein (4; for review see reference 47). A most likely candidate for this "stop transfer signal" could be the membrane-binding region of group I proteins. Such a role for this region is supported by a great deal of evidence derived both from natural variants of certain proteins and more recently from studies with mutations engineered in vitro. The evidence may be arranged into several categories. Firstly, loss of both hydrophobic domain and cytoplasmic tail, as would be predicted, leads to secretion from the cell (IgG, IgM, IgA, and IgD [e.g., 2, 44], Herpes envelope protein [24] , and H-2 related pH 16 [30] are natural variants; influenza hemagglutinin [17] , and Vesicular Sto-matis virus glycoprotein [VSV-G] ~ [45] are derived from deliberate engineering). Alternatively, the truncated proteins are still cell associated but no longer transmembrane proteins (one mutant of the low density lipoprotein receptor provides a natural example [32] ; phage F1 gene III protein [5] and Rous Sarcoma virus envelope protein [53] are engineered examples). These data do not exclude the possibility that the cytoplasmic tail could be involved in anchoring. However, there are examples of proteins in which the normal cytoplasmic tail alone has been partially or completely (with the exception of the charge cluster) removed, and membrane association is apparently not affected. H-2 antigens (56), VSV-G (46), influenza hemagglutinin (12), Semliki Forest virus (SFV) E2 ( ! 5), and Rous Sarcoma virus envelope protein (53) have all been investigated in this respect. To demonstrate that the functioning of the hydrophobic domain is also independent of the lumenal domain, the lumenal domains of several group I proteins have been exchanged generating fusion proteins that are still membrane associated (FI gene III protein/ gene VIII protein [5] , SFV-E2/VSV-G [43] , SFV-E2/Fowl Plague virus-hemagglutinin [43] , growth hormone/VSV-G [19] , and influenza hemagglutinin/VSV-G [38] ). Finally, and most elegantly, Yost et al. (54) placed the membrane-binding polypeptide region of an IgM heavy chain between the bacterial ¢~-lactamase (NH2-terminal) and chimpanzee a-globin (COOH-terminal). This chimera had the topology predicted by the stop transfer postulate.
We decided to study the features of the membrane-binding region of a group I polypeptide that are important for its function using the extremely powerful approach of in vitro mutagenesis followed by in vivo expression. The model protein we are using is the well-characterized group I protein p62/E2 of SFV (14, 48) (see also Figs. 1 and 4) . The p62 protein is a 486-amino acid residues-long transmembrane spike glycoprotein which is synthesized in the rough endoplasmic reticulum and then transported as a complex with the other SFV spike glycoprotein E1 to the cell surface. At the plasma membrane, the p62 protein is cleaved after residue 66 to form E3 and E2. The p62/E2 protein has a 3 l-residue COOH-terminal cytoplasmic tail with a "typical" charge cluster (Arg-Ser-Lys) flanking the transmembrane domain. Using oligonucleotide-directed mutagenesis, three mutants have been produced in the membrane-binding region: A 1, changing the positive charge cluster from Arg-Ser-Lys (+2) to Gly-SerGlu (-1); A2, substitution of the negatively charged Glu for an Ala in the middle of the uncharged hydrophobic spanning region; A3, changing the charge cluster from wild type (+2) to Gly-Ser-Met (0).
The phenotypes of the p62/E2 mutants will depend on the function of the altered regions in translocation arrest and membrane binding. It was originally proposed (4) that a "stop transfer" signal was recognized by some element of the translocation machinery, causing the disassembly of a proteinaceous tunnel in the membrane through which secretory and membrane proteins are translocated, thereby trapping a membrane protein in the bilayer. According to this model, the mutants might no longer have functional signals and the Abbreviations used in this'paper: DME, Dulbecco's modified Eagle's medium: dsDNA, double-stranded DNA: SFV, Semliki Forest virus: ssDNA, singlestranded DNA; VSV-G, Vesicular Stomatitis virus glycoprotein.
tunnel might then remain in place. The proteins would then complete translocation becoming lumenal proteins, either cell associated or secreted. On the other hand, if the membranebinding region interacts either directly with the lipid bilayer, or is recognized in a degenerate fashion by the translocation machinery, then the mutations may have more subtle effects on membrane binding and/or topology. The mutant phenotypes would then reflect the relative roles of the two features of this region in establishment and maintenance of topology.
In this paper, we show that all three mutants are still membrane associated in a functionally unaltered fashion since they are all capable of reaching the cell surface where they can promote normal low pH-triggered cell-cell fusion. In the accompanying paper we assay the topology and membranebinding capacity of the SFV-A mutants directly.
Materials and Methods

General DNA Manipulations
Except where stated, all enzymes were from Boehringer Mannheim Biochemicals, Indianapolis, IN or New England Biolabs, Beverly, MA. General molecular biological techniques were performed as described (35) . Transformation of Escherichia coli (except where otherwise stated, strain 71/18 [40] ) was performed as in Hanahan (21) . Preparation of DNA was as described (27) .
Vectors
To construct pSFd, the origin of replication of the phage FI was isolated from pD4 (l l) as an EcoRl fragment, and the ends were filled in and then ligated into pS-S-SFV at the PvulI site. One of the two EcoRl sites was recreated (see Fig. 2 a) .
Wild-type pS-S-SFV has been described elsewhere (27) . pLI-SFV was obtained by isolating the Hind Ill-Hind Ill fragment which codes for the SFV structural proteins from pS-S-SFV, filling in the ends, adding Barn HI linkers, and cloning it into the unique BamHl site of pAl I-SVL2 (18) .
pLI-SFV-d9 was derived from pSV2-SFV-d9 (one of the series of the SFV deletion mutations described by Garoff et al. [15] ). The deletion mutant d9 encodes capsid and p62 but not El. In d9, the truncated 6K is followed by eight aberrant amino acids introduced by the stop translation linker (Garoff, H., unpublished data), pLI-SFV-d9 was produced by a three-fragment ligation. Fragments were prepared as follows. (a) pSV2-SFV-d9 was linearized with Hind Ill, the ends filled in and BamHI linkers added. This was then cleaved with Clal and the Clal-BamHI fragment containing the SFV coding region was isolated. (b) pkTH601 (41) was cut with BamHI and Cla I and the small fragment containing the translation stop linker was isolated. (c) pAII-SVL2 was cut with BamHl and treated with phosphatase. All three isolated fragments were then ligated together, and colonies resulting from transformation screened for pLI-SFV-d9 by restriction analysis.
Mutagenesis
Oligonucleotides were purchased from Dr. Kaplan, City of Hope, Research Institute, Duarte, CA.
Mutagenesis of SFV-AI and A2. Following the procedures of Dente et al. (10) , single-stranded DNA (ssDNA) was prepared from pSFd. The conversion of this material to double-stranded (ds) pSFd incorporating the mutagenic oligonucleotide in vitro was as described in Zoller and Smith (55) using Klenow (Bethesda Research Laboratories. Gaithersburg, MD) and T4-DNA ligasc (kind gift of F. Winkler, Hoffman-LaRoche, Basel, Switzerland). The heteroduplex was cut with SstII, the small fragment isolated and ligated into the large fragment isolated from Sstll-digested, phosphatase-treated pS-S-SFV. This ligation was used to transform E. coli and resultant colonies were screened for mutants by hybridization to the mutagenic oligonucleotide as described in Canner et al. (7), The putative mutants of pS-S-SFV were digested with Pvull and Scal, and the ends were filled in. The small fragment isolated and ligated into M 13 mp8 (39, 40) that had been cut with Sinai and phosphatased (see Fig. 2 b) . M I3 mp8-SFV was then used for confirmatory sequencing between the Sstll sites using the dideoxy chain-terminating method. The mutant pS-S-SFVs were then used for expression or used for subcloning the mutants into pL1-SFV and pLI-SFV-d9.
Mutagenesis ofSFV-A3. M I3 mp8-SFV was generated from wild-type pS-S-SFV as described above. MI3 mpl8 was digested with EcoRl and Hind Ill. The large fragment was isolated and 2 pmol incubated in 16 #1 of buffer A (25 mM Tris, pH 7.5, 60 mM NaCI, 12.5 mM MgCI2, 2 mM dithiothreitol) at 95"C for 10 min. 0.5 pmol (l #1) of ssMl3 mpS-SFV was added and the material transferred to 65"C for l h, followed by addition of 30 pmol (3 ul) of kinased oligonucleotide. The mixture was then slowly cooled to room temperature. 18 ul of buffer C (buffer A + 1 mM of each dNTP + 1 mM ATP)followed by 1 U DNA ligase and 2.5 U DNA polymerase 1 (large fragment) were added, and incubated for 3 h at 16"C. Aliquots were used to transform ES871 (6), and hybridization screening was carried out as for SFV-A1/A2. Confirmatory sequencing between Sst-Ii sites was carried out by the dideoxy method in m13 mplS-S-SFV and the SstII-Sstll fragment was subeloned into the various expression vectors.
DEAE-Dextran-mediated Transfection of COS-7 Cells
Subconfluent monolayers of COS-7 cells (-2 x 10 ~ cells) on 5-cm dishes were transfected as follows. Plasmid DNA was diluted in RPMI 1640 (Gibeo, Grand Island, NY) to 4 #g/ml and mixed with an equal volume of DEAE--dextran (Pharmacia Fine Chemicals, Piscataway, NJ; molecular weight, 5 x 105) in RPMI 1640 at a concentration of 2 mg/ml. Cells were washed twice with RPMI and then incubated with the DNA mix (1 ml/dish). After 1 h at room temperature, 5 ml of Dulbecco's modified Eagle's medium (DME) with 10% fetal calf serum and 10% dimethyl sulfoxide were added. 3 min later, the cells were washed twice with DME plus 10% fetal calf serum supplemented with 40 uM chloroquine (Sigma Chemical Co., St. Louis, MO) and left in this solution for 6 h at 37"C. The cells were then washed and incubated for 30 or 40 h at 37"C in 5 ml DME plus 10% fetal calf serum before labeling, fixation, or lysis.
Microinjection, Immunofluorescence, Western Blotting, and Gel Electrophoresis
Microinjection and indirect immunofluorescence were performed as described (50) . Western blotting was performed as described in Kondor-Koch et al. (27) . Quantitation of Western blots was performed as follows: ~251-protein A (New England Nuclear, Boston, MA) was used as a second antibody instead of peroxidase-conjugated sheep anti-rabbit IgG (Biosys, Compiegne, France). The blot was rinsed, air dried, and exposed to X-ray film between screens (Cronex double-lightning; DuPont Co., Wilmington, DE). Autoradiographs were scanned on a Helena Laboratories Quick Scan densitometer (Desaga, Heidelberg, Federal Republic of Germany), and peaks were cut out and weighed.
Fusion Assay
The assay for cell-cell fusion after microinjection of BHK-21 cells has been described (27) .
Biosynthetic Labeling and Use of Tunicamycin
Cells were labeled 30 h after transfection with [35S]methionine (800 Ci/mmol; Amersham Corp., Arlington Heights, IL) at I mCi/5-cm dish. The cells were washed twice with DME minus methionine, starved for 15 min, and then incubated in DME minus methionine plus the [35S]methionine for 1 h. To study glycosylation, cells were incubated in 4 ~M tunicamyein (CalbiochemBehring Corp., La Jolla, CA) for 2.5 h, labeled for 1 h (in the presence of tunicamyein), and then lysed.
Immunoprecipitation 5-cm dishes of transfected cells were placed on ice and washed twice with icecold phosphate-buffered saline. This was replaced with 500 ,~1 of lysis buffer (1% Nonidet P-40, 150 mM NaCI, 50 mM Tris, pH 7.5) supplemented with a range of protease inhibitors (phenylmethylsulfonyl fluoride, leupeptin, trasylol, pepstatin, benzamidine, and antipain [all from Sigma Chemical Co.], used as described in reference 37). After 5 min on ice, the cell lysate was removed and spun for 2 rain in a microfuge to remove nuclei and other insoluble material. For immunoprecipitation, the volume and composition of the buffer were then adjusted to 1% Nonidet P-40, 1% deoxycholate, 0.1% SDS, 150 mM NaCI, 50 mM Tris, pH 7.6, in 1 ml. 50 ul of Pansorbin (Calbiochem-Bchring Corp.) washed in lysis buffer was added and the lysate rocked at room temperature for 30 min. After centrifugation at 100,000 g for l h at 4"C, the supernatant was incubated overnight at 4"C with 1 ul rabbit anti-E2 IgG or l0 ~1 of an aMnity-purified fraction prepared from this. 50 ul of Pansorbin was added, and the mixture rocked at room temperature for 30 min. The Pansorbin was then repeatedly washed and pelleted in a microfuge with the following buffers: lysis buffer plus 5 mM EDTA (twice); lysis buffer plus EDTA plus 350 mM NaC1 (once); and 10 mM Tris, pH 7.5 (twice). The final pellet was re,suspended in 50 ul of sample buffer (200 mM Tris, pH 8.8, 1.0 M sucrose, 0.01% bromophenol blue, 5 mM EDTA, 4% SDS), reduced with dithiothreitol, heated to 95"C for 5 min, and alkylated with iodoacetamide.
Results
Construction of the SFV-A Mutants
The three mutants of the membrane-binding polypeptide region ( Fig. 1 ) of p62/E2 have been constructed using oligonucleotide-directed mutagenesis (55) . Briefly, the procedure begins with generating an ssDNA copy of the region to be mutated. An oligonucleotide containing the desired alterations plus wild-type overlaps at each end is hybridized to the ssDNA template and used as a primer for DNA polymerase I to convert this material back to dsDNA in vitro. The in vitrosynthesized heteroduplex is then replicated in vivo and daughter plasmids containing the mutation are isolated. Fig. I . The oligonucleotides were designed both to make the desired amino acid changes and to introduce new restriction sites into the DNA to facilitate screening for mutated plasmids. Al and A3 introduce HpaII sites (CCGG), whereas A2 introduces a TaqI site (TCGA). The strategies used for mutagenesis (Fig, 2 , a and b) were designed to minimize undesired mutations caused by the oligonueleotide hybridizing to secondary sites on the template ssDNA, resulting in false positives during screening. Because the SFV eDNA is 3,983 base pairs long (14) , many such sites existed, and were used by the mutagenic oligonucleotides (Cutler, D., unpublished observations). Thus, for SFV-A 1 and SFV-A2 (Fig. 2a) , the region of mutagenized DNA that was screened was limited to a 149-base pair SstlI-SstlI fragment transferred to a wild-type vector. The ssDNA template for SFV-AI and SFV-A2 was produced using the approach of B. Scheme of mufngenesis forSFV-A3 (10) . The portion ofa ssDNA phage (FI) required in cis for generation of SSDNA was cloned into the SV40-based expression vector pS-S-SFV (see Fig. 3 a) to give pSFd (Fig. 2 a) . Superinfection of bacteria harboring this plasmid with a helper phage allows the isolation of sspSFd. The use of pSFd allowed mutants to be rapidly tested by expression. The efficiency of mutagenesis with this system was -0.5-1%.
For the creation of SFV-A3 (Fig. 2 b) , the initial target for hybridization of the oligonucleotide was limited to a 750-base pair Pvu II-Sca I segment by a gapped heteroduplex approach (28). The single-stranded template/'or SFV-A3 was produced by subcloning the 750-base pair fragment of the SFV eDNA into a plasmid based on an ssDNA phage, M13-mp8 (39), to produce M13-mp8-SFV. The use of the mp8/mpl8 gapped duplex strategy allows genetic selection for the mutagenized daughter plasmids; by using the nonsuppressor host ES781 (6), lhe mp8-derived wild-type daughter plasmids are selected against since rap8 (unI~ke mpI 8) carries two amber mutations. ES781 has the additional advantage that it also lacks the Mutt mismatch repair system and so will not convert the heteroduplex plasmids to homoduplexes, a process which normally favors the in vivo-methylated wild-type strand and therefore reduces the yield (29) . The efficiency of mutagenesis in M13mp8-SFV was about 10-fold greater than with pSFd, 5-10%. All three mutants were isolated by hybridization screening (7) followed by restriction analysis and confirmed by sequencing using the dideoxy method between the two flanking SstII sites (Fig. 3) . The Sstll-SstII fragment was then subcloned into the expression vectors used in these studies ensuring ~hat only the desired mutations were present ir~ the protein~ being analyzed.
Expression of p62/E2 with and without E1
The SstlI-SstlI fragments encoding the A-mutants were cloned into two different kinds of SFV expression plasmids; pS-S-SFV and pL1-SFV. The first (Fig. 4a) is based on the SV40 early region and has been described (27) . The latter (Fig. 4b) is the SV40 late region expression vector of Gruss et al. (18) with the SFV-cDNA inserted (Melancon, P., unpublished data). The pS-S:SFV series of plasmids encoding wildtype and mutant cDNAs were used for microinjection experiments. The pLI-SFV series were transfected into COS-7 cells where the endogenously expressed T-antigen promotes replication and transcription from the late region of SV40 DNA. This amplification facilitated experiments where the proteins produced were analyzed by electrophoresis. Since El, which is co-expressed with p62 from gFV expression plasmids, may he?l~ to stabilize the latter }n the membrane (m the p62-E1 spike complex) and theretbre mask alterations in ~t5 phenotype, p62 has been expressed and analyzed both in the presence and the absence of E1 (see Fig. 5 ). To express p62 in the absence of El, we have used the plasmid pL1-SFV-d9 where the SFV eDNA is truncated in the middle of the 6K-peptide region (up to the codon for Ala 24). This 60-amino acid residue peptide is found between p62 and E1 and is cleaved away eo-translationally. The p62 protein produced from pL1-SFV-d9 wilt, most likely, undergo normal E2/6K cleavage and give rise to a p62 without the aberranl amino acids at its carboxyl lerminus commonly introduced in lruncations (e.g., 9 . rS). The ~runcation SFV-d9 ~F~g. 5) }s or2e of a series described elsewhere (15) and has been subcloned into pAll-SVL2 to produce pL1-SFV-d9 (Fig. 4c and Materials and Methods).
Size and Glycosylation of the SFV-A Mutants
The first analysis of the SFV-A mutants was designed to show that the wild-type and mutant p62 proteins expressed from both pL1-SFV and pLI-SFV-d9 are the expected sizes, with and without oligosaccharides. Accordingly, two sets of all eight plasmids (wild-type and mutants, pLI-SFV and pkl- SFV-d9) were transfected into COS-7 cells using DEAEdextran (Materials and Methods). 30 h after transfection, one set of dishes was treated with tunicamycin and both were then pulse labeled with [35S]methionine followed by solubilization, immunoprecipitation, gel electrophoresis, and fluorography (Fig. 6) . Lanes 2-9 show that in cells transfected with pL1-SFV (and therefore co-expressing E2 and El), the AI and A3 forms of p62s migrate with the wild-type p62 both in the presence (a) or the absence (b) of NH2-1inked sugars. The concentration of tunicamycin sufficient to completely prevent N-glycosylation also inhibits protein synthesis considerably (compare even and odd tracks). The A2 form of p62, on the other hand, consistently migrates a little slower on SDS polyacrylamide gels, a pattern maintained in the presence of tunicamycin. In cells transfected with pLI-SFV-d9 and therefore lacking E 1 (tracks 10-17), p62 migrates as a doublet. The major, faster-migrating form of p62 co-migrates with p62 produced in the presence of E 1. This is consistent with the expected E2/6K cleavage. The A-mutants are glycosylated as wild-type, A2 again migrating slower. The slower migrating p62 form seen in the absence of E1 is probably not the uncleaved p62-6K protein since the predicted difference in molecular weight resulting from this cleavage in SFV-d9 is too small to account for the difference in mobility, p62 often runs as multiple bands on SDS gels (see, for example, reference 15), possibly due to different conformations of this cysteine-rich protein. It may be that the absence of E 1 exaggerates this tendency--more marked in the case of A2 (see lane 4 where a doublet occurs even in the presence of E 1). An alternative possibility, that the upper band is an intermediate in posttranslational modification has been tested. A 4-h chase does not alter this banding pattern (Cutler, D., unpublished observations). However, the doublet is not always present in samples analyzed by Western blot 40 h after transfection (see, for example, Fig. 3 in the following paper), and therefore may result from some incomplete posttranslational modification. The aberrant mobility of A2-p62 may be due to altered SDS binding since a charge has been placed into the most hydrophobic portion of the molecule. Interestingly, the level of expression of p62 is approximately three-to fivefold better in the absence of E 1. Shortening the SFV cDNA consistently produces higher levels of expression after DEAE--dextran transfection (Melancon, P., and D. Cutler, unpublished observations). Lane 1 shows the nonspecific bands immunoprecipitated in this experiment.
Cell Surface Transport of the SFV-A Mutants
One of the simplest ways to test whether or not the A-mutants are still membrane associated is to look for cell surface expression. If the proteins are on the cell surface then they are still membrane associated. Moreover, we can use cell surface transport as a screen against possible pleiotropic effects of mutagenesis since the cellular machinery will often fail to transport proteins with even relatively small alterations in primary structure (3) . Unaltered cell surface transport would be evidence of a functionally unaltered protein. Accordingly, Can the A-mutant p62 proteins reach the cell surface in the absence of El? Transfection of COS-7 cells with the four pL1-SFV-d9 plasmids followed by surface and internal indirect immunofluorescence (Fig. 8) shows that E1 is not required for surface appearance of the wild-type and the A-mutants of p62.
A fluorescent analysis of surface transport has limitations. It will not reveal small differences between wild-type and mutant p62s and cannot be used to rule out the possibility that only a subpopulation of the protein is reaching the cell surface. To pursue these latter points, the posttranslational processing of p62 into E3 + E2 has been exploited to achieve an indirect measure of cell surface appearance. This cleavage is taking place either on the cell surface and/or just before the p62 proteins arrive to the cell surface; E2 is not found within the cell but only on its surface and in budded virions during infection (48) . Transfection experiments reported earlier (l 5, 27) and in the accompanying paper (see in particular Fig. 3 of that report) have shown that efficient cleavage can only be obtained when the p62 protein is co-expressed with the E1 glycoprotein. Presumably, the El-p62 interaction in the SFV spike glycoprotein supports a conformation recognized by the endoprotease. Furthermore, it is evident from Fig, 6 in this paper that long incubation times are needed to process the p62 protein in pL1-SFV DNA-transfected COS cells. After a l-h pulse (without chase) of transfected cells, there is still very little E2 protein appearing both for wild-type and mutants (see faint band co-migrating with a nonspecific one in the 50-kD region in lanes 2-9 of Fig. 6 ). For these reasons, the ratio of total p62 to E2 has been measured in cells 40 h after transfection, in the presence of El, using the pLI-SFV wildtype and mutant DNAs. After solubilization, samples were electrophoresed and transferred to nitrocellulose and stained with anti-E2 antibody followed by 125I-protein A. Autoradiographs were scanned for quantitation. The results of three experiments (Table I) show E2/p62 ratios of about 2 both for the wild-type protein and all of the mutants. We conclude that all p62 mutants are transported to the cell surface with an efficiency similar to that of wild-type p62 protein.
Fusogenic Activity of the SFV-A Mutants
A function of the SFV spike complex that is directly related to its membrane binding is its activity as a fusogen. For the spike to promote fusion it must be anchored in a lipid bilayer (36). It might be thal fusion activity would be a very sensitive assay for functionally intact membrane binding. BHK-21 cells were microinjected with the four pSV-S-SFV plasmids containing the wild-type and A-mutant SFVs, left for 6 h, then briefly treated with low pH. After fixation, the cells were stained with anti-E2 antibody and photographed. Fig. 9 shows that all three mutant spikes, like the wild-type spike, exhibit fusogenic activity. In all cases, the microinjected cells express- In this paper the generation of three mutants of the membrane-binding polypeptide region of SFV-p62/E2 is described. After expression, the mutated DNAs express proteins of the predicted size. These are glycosylated and transported to the cell surface as is the wild-type p62/E2, both in the presence and absence of El. Moreover, all three spikes made with mutated p62/E2 display fusogenic activity.
The demonstration of normal cell surface appearance and fusogenic activity for the SFV-A mutants rules out the possibility that the mutations have completely destroyed the functioning of the membrane-binding region of the p62/E2 polypeptide. Moreover, cell surface appearance is an important feature of our mutants since we wanted to make only those minimal alterations to p62/E2 structure that are consistent with alterations to its membrane-binding polypeptide region. The field of mutagenesis/expression shows many examples where engineering at the DNA level has led to impaired intracellular transport (e.g., references 12, 19, 38, and 46). These results are often very difficult to interpret and so we have attempted to produce proteins that are as little perturbed as possible; efficient cell surface transport argues that we have achieved this.
Our results with A2 are in contrast with those recently published by Adams and Rose (1) . They show that the subCells transfected with indicated DNAs were solubilized after 40 h. Samples were Western blotted and stained with anti-E2 antibody followed by J:Slprotein A. Autoradiographs were scanned, peaks cut out, and weighed. Data presented is the mean of three experiments _+ SEM. * The weight of the E2 peak/the weight of the I)62 peak. stitution of an Arg for an Ile in the middle of the hydrophobic stretch of VSV-G seriously inhibits its surface transport. There are at least two possible reasons for this difference in result. If the interaction between lipid bilayer and hydrophobic spanning stretch is important for intracellular transport then disrupting this interaction could inhibit that transport. Arg could well be more disruptive than Glu (31) . Moreover, while the membrane-spanning stretch of VSV-G is defined by a charge at both ends, that of p62/E2 does not have a charge-defined NH2-terminal border (see Fig. 1 ). Thus p62/E2 may be able to slide upstream in the mechanism, thereby avoiding the problem of burying a charge in the bilayer. A second possibility is that oligomerization .of VSV-G is important for its cell surface transport and that the mutation affects this. In the case of SFV, the spike of which is a hetero-oligomer (unlike the glycoprotein of VSV), it could be either that Glu does not affect oligomerization or that the transport of p62 is not very sensitive to its oligomeric state. This may well be so since p62 can reach the cell surface in the absence of E 1.
We have argued that since membrane binding of spike proteins is essential for fusion (36) and all three mutants of p62/E2 cause cell-cell fusion, all three SFV-A-mutants have unaltered membrane binding. However, the fusion activity of the SFV spike has only been found when the whole complex is expressed; p62 expressed alone cannot cause fusion (27) . This result implies that SFV-E1 may have a primary role in fusion. However, when expressed alone, El, although glycosylated and therefore translocated, does not reach the cell surface (22, and Melancon, P., unpublished data) and therefore we have no positive confirmation of a primary fusogenic role for E1 in SFV. Thus, it may be that both E1 and E2 are required in concert to mediate fusion (52) . That our mutations do not appear to affect fusion may therefore reflect either that p62/E2 is not involved in fusion or that they do not impair functional membrane binding ofp62/E2.
Both assays of membrane association presented here are functional and therefore indirect. It could be that the position and/or stability of the mutant proteins in the membrane is altered in these mutants despite their unimpaired functioning. In the following paper, we directly address these questions.
The general implication of the results presented here is that it is unlikely that a specific structure present in the membrane-binding polypeptide region is being recognized by some machinery involved in translocation leading to the halting of transfer. Our data tend to support a model in which a general hydrophobicity causes a transmembrane protein to assume its three-domain structure, and that an intact charge duster and uninterrupted hydrophobic stretch are not important for this function.
